Advertisement
Advertisement

AVXL

AVXL logo

Anavex Life Sciences

2.86
USD
Sponsored
+0.01
+0.35%
Sep 04, 15:59 UTC -4
Closed
exchange

After-Market

2.90

+0.04
+1.43%

AVXL Earnings Reports

Positive Surprise Ratio

AVXL beat 27 of 39 last estimates.

69%

Next Report

Date of Next Report
Nov 23, 2026
Estimate for Q4 26 (Revenue/ EPS)
--
/
-$0.11
Implied change from Q3 26 (Revenue/ EPS)
--
/
+37.50%
Implied change from Q4 25 (Revenue/ EPS)
--
/
--

Anavex Life Sciences earnings per share and revenue

On Aug 25, 2026, AVXL reported earnings of -0.08 USD per share (EPS) for Q3 26, beating the estimate of -0.08 USD, resulting in a 1.96% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +14.47% price change (close before vs. close after earnings).
Looking ahead to Q4 26, 5 analysts forecast an EPS of -0.11 USD, with revenue projected to reach -- USD, implying an increase of 37.50% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Clinuvel Pharmaceuticals Limited - ADR
Report Date
Aug 27, 2026 For Q4 26
Estimate
$0.50
Actual
-
Surprise
-
logo
Molecular Partners AG - ADR
Report Date
Aug 25, 2026 For Q2 26
Estimate
-
Actual
-$0.35
Surprise
-
FAQ
For Q3 2026, Anavex Life Sciences reported EPS of -$0.08, beating estimates by 1.96%, and revenue of $0.00, 0% as expectations.
The stock price moved up 14.47%, changed from $3.11 before the earnings release to $3.56 the day after.
The next earning report is scheduled for Nov 23, 2026.
Based on 5 analysts, Anavex Life Sciences is expected to report EPS of -$0.11 and revenue of -- for Q4 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement